Critical Success Factors for Innovations in the Health Care Market

About the Talk:

Great ideas and great minds – is this all it takes to get inventions into the health care market? Dr. Inge Bliestle, life science business expert, shares her insights from a 25-year innovation & entrepreneurship-career in Pharma and Medtech. She elaborates on when and how great ideas become market-ready innovations with a particular focus on the essential role unmet needs play in this regard.

Learn about the peculiarities of the health care market (e.g., stakeholder-trinity, pricing mechanisms, development cycles) and how they affect the development and successful market launch of an innovation in the upcoming session of our LMU IEC Talk Series!

About the speaker:

Inge Bliestle, PhD, is an entrepreneur, consultant and mentor with a passion to turn recent R&D findings into patients’ benefits and successful business. She is a biochemist by training and has more than 25 years of experience in pharma, medtech and biotech, e.g., Boehringer Ingelheim, GSK, Abbott, GN Resound, and Actelion in increasing responsibilities up to GM roles. Dr. Bliestle has launched approx. 15 new products primarily in speciality and orphan diseases. She is a member of the Go Bio Initial Jury and has been working with a variety of startups. Dr. Bliestle offers a holistic approach to consulting and implementation along all phases of the life-cycle from early business cases, pre-launch, launch, and turn-around. This includes support in fundraising, development of brands, building effective organizations, structures and leadership, impactful communications, and networking.